ELOVL4

From Wikipedia, the free encyclopedia


Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4
Identifiers
Symbol(s) ELOVL4; ADMD; STGD2; STGD3
External IDs OMIM: 605512 MGI1933331 HomoloGene41488
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 6785 83603
Ensembl ENSG00000118402 ENSMUSG00000032262
Uniprot Q9GZR5 Q8JZV3
Refseq NM_022726 (mRNA)
NP_073563 (protein)
NM_148941 (mRNA)
NP_683743 (protein)
Location Chr 6: 80.68 - 80.71 Mb Chr 9: 83.58 - 83.6 Mb
Pubmed search [1] [2]

Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4, also known as ELOVL4, is a human gene.[1]


[edit] References

[edit] Further reading

  • Zhang K, Bither PP, Park R, et al. (1994). "A dominant Stargardt's macular dystrophy locus maps to chromosome 13q34.". Arch. Ophthalmol. 112 (6): 759-64. PMID 8002833. 
  • Stone EM, Nichols BE, Kimura AE, et al. (1994). "Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q.". Arch. Ophthalmol. 112 (6): 765-72. PMID 8002834. 
  • Edwards AO, Miedziak A, Vrabec T, et al. (1999). "Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14.". Am. J. Ophthalmol. 127 (4): 426-35. PMID 10218695. 
  • Zhang K, Kniazeva M, Han M, et al. (2001). "A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.". Nat. Genet. 27 (1): 89-93. doi:10.1038/83817. PMID 11138005. 
  • Li Y, Marcos I, Borrego S, et al. (2001). "Evaluation of the ELOVL4 gene in families with retinitis pigmentosa linked to the RP25 locus.". J. Med. Genet. 38 (7): 478-80. PMID 11474659. 
  • Edwards AO, Donoso LA, Ritter R (2001). "A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family.". Invest. Ophthalmol. Vis. Sci. 42 (11): 2652-63. PMID 11581213. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Rivolta C, Ayyagari R, Sieving PA, et al. (2003). "Evaluation of the ELOVL4 gene in patients with autosomal recessive retinitis pigmentosa and Leber congenital amaurosis.". Mol. Vis. 9: 49-51. PMID 12592226. 
  • Lagali PS, Liu J, Ambasudhan R, et al. (2003). "Evolutionarily conserved ELOVL4 gene expression in the vertebrate retina.". Invest. Ophthalmol. Vis. Sci. 44 (7): 2841-50. PMID 12824221. 
  • Vrabec TR, Tantri A, Edwards A, et al. (2003). "Autosomal dominant Stargardt-like macular dystrophy: identification of a new family with a mutation in the ELOVL4 gene.". Am. J. Ophthalmol. 136 (3): 542-5. PMID 12967813. 
  • Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6.". Nature 425 (6960): 805-11. doi:10.1038/nature02055. PMID 14574404. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi:10.1038/ng1285. PMID 14702039. 
  • Ambasudhan R, Wang X, Jablonski MM, et al. (2004). "Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.". Genomics 83 (4): 615-25. doi:10.1016/j.ygeno.2003.10.004. PMID 15028284. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Grayson C, Molday RS (2005). "Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.". J. Biol. Chem. 280 (37): 32521-30. doi:10.1074/jbc.M503411200. PMID 16036915. 
  • Lai Z, Zhang XN, Zhou W, et al. (2006). "Evaluation of the ELOVL4 gene in a Chinese family with autosomal dominant STGD3-like macular dystrophy.". J. Cell. Mol. Med. 9 (4): 961-5. PMID 16364203. 
  • Hubbard AF, Askew EW, Singh N, et al. (2006). "Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation.". Arch. Ophthalmol. 124 (2): 257-63. doi:10.1001/archopht.124.2.257. PMID 16476896. 
  • Seitsonen S, Lemmelä S, Holopainen J, et al. (2006). "Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population.". Mol. Vis. 12: 796-801. PMID 16885922. 
  • McMahon A, Butovich IA, Mata NL, et al. (2007). "Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.". Mol. Vis. 13: 258-72. PMID 17356513.